Exchange Traded Concepts, LLC Vir Biotechnology, Inc. Transaction History

Exchange Traded Concepts, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 12, 2023	SELL	$22.26 - $30.85 $488,829 - $677,466	-21,960 Reduced 45.13%	26,701 $621,000
Q4 2022 Jan 17, 2023	BUY	$19.96 - $28.22 $29,540 - $41,765	1,480 Added 3.14%	48,661 $1.23 Million
Q3 2022 Oct 07, 2022	BUY	$18.26 - $31.1 $861,525 - $1.47 Million	47,181 New	47,181 $910,000
Q2 2021 Jul 30, 2021	SELL	$38.75 - $51.0 $6,626 - $8,721	-171 Closed	0 $0
Q1 2021 Apr 20, 2021	BUY	$26.34 - $83.07 $4,504 - $14,204	171 New	171 $9,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $991M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.